Effects of a 4-Week Altitude Training on Sport-Specific Performance, Body Composition, and Cardiac and Pulmonary Function in Adolescent Male Rowers

May 28, 2026 updated by: Chaoran Han, Macao Polytechnic University

Effects of a 4-Week Altitude Training on Sport-Specific Performance, Body Composition, and Cardiac and Pulmonary Function in Adolescent Male Rowers: The Potential Role of Maturation

This study aims to investigate the effects of a 4-week altitude training program on adolescent male rowers. The research will examine changes in athletic performance, athletic body composition, athletic cardiac function, athletic pulmonary function, and selected blood markers. Participants will be stratified by biological maturation based on peak height velocity to explore whether maturity influences athletic training adaptations. Measurements will include non-invasive assessments of athletic performance, athletic body composition, athletic heart and lung function, as well as venous blood sampling for hematological markers. The study intends to provide evidence for optimizing high-altitude training strategies in youth rowing.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Macao
      • Macao, Macao, China
        • Recruiting
        • Macao Polytechnic University, Faculty of Health Sciences and Sports
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:Male adolescent rowers aged 12-19 years Regularly training and participating in competitive rowing Willing to participate in 4-week altitude training program and follow testing protocol -

Exclusion Criteria:Any cardiovascular, respiratory, hematologic, or musculoskeletal disorders Injury or illness preventing participation in high-intensity rowing training Participation in another high-altitude training program within the last 3 months Any medical contraindication to blood sampling

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Post-PHV group
Participants in the Post-PHV group are adolescent male rowers stratified by biological maturation (PHV offset). They will undergo the same 4-week high-altitude training program, including aerobic, anaerobic, and sport-specific rowing exercises. Pre- and post-training measurements of athletic performance, athletic body composition, athletic cardiac and pulmonary function, and hematological markers will be collected.
Participants undergo a 4-week altitude training program, including aerobic, anaerobic, and sport-specific rowing exercises. Both Post-PHV and Mid-PHV groups receive the same training protocol. Pre- and post-training assessments include athletic performance, athletic body composition, athletic cardiac and pulmonary function, and hematological markers. Participants are stratified by biological maturation (PHV offset) to explore whether maturity influences training adaptations.
Experimental: Mid-PHV group
Participants in the Post-PHV group are adolescent male rowers stratified by biological maturation (PHV offset). They will undergo the same 4-week high-altitude training program, including aerobic, anaerobic, and sport-specific rowing exercises. Pre- and post-training measurements of athletic performance, athletic body composition, athletic cardiac and pulmonary function, and hematological markers will be collected.
Participants undergo a 4-week altitude training program, including aerobic, anaerobic, and sport-specific rowing exercises. Both Post-PHV and Mid-PHV groups receive the same training protocol. Pre- and post-training assessments include athletic performance, athletic body composition, athletic cardiac and pulmonary function, and hematological markers. Participants are stratified by biological maturation (PHV offset) to explore whether maturity influences training adaptations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak Power During Wingate Test
Time Frame: Pre-training and immediately post 4-week altitude training
Peak power measured during the Wingate anaerobic test before and after the intervention.
Pre-training and immediately post 4-week altitude training
Maximal Oxygen Uptake
Time Frame: Pre-training and immediately post 4-week altitude training
Pre- and post-intervention measurement of VO₂max using standard exercise testing protocol to assess aerobic capacity in adolescent male rowers.
Pre-training and immediately post 4-week altitude training
Mean Power Output During 1500 m Rowing Test
Time Frame: Pre-training and immediately post 4-week altitude training
Mean power output measured during the 1500 m rowing ergometer test before and after the intervention.
Pre-training and immediately post 4-week altitude training
Body Weight
Time Frame: Pre-training and immediately post 4-week altitude training
Body weight measured before and after the training period.
Pre-training and immediately post 4-week altitude training
Body Fat Percentage
Time Frame: Pre-training and immediately post 4-week altitude training
Body fat percentage measured using bioelectrical impedance or other validated method.
Pre-training and immediately post 4-week altitude training
Forced Vital Capacity (FVC)
Time Frame: Pre-training and immediately post 4-week altitude training
Forced vital capacity measured using spirometry before and after the intervention.
Pre-training and immediately post 4-week altitude training
Maximal Voluntary Ventilation
Time Frame: Pre-training and immediately post 4-week altitude training
MVV measured using standard pulmonary function testing protocol pre- and post-intervention.
Pre-training and immediately post 4-week altitude training
Left Ventricular Volume
Time Frame: Pre-training and immediately post 4-week altitude training
Echocardiography measurement of left ventricular end-diastolic and end-systolic volume.
Pre-training and immediately post 4-week altitude training
Ejection Fraction
Time Frame: Pre-training and immediately post 4-week altitude training
Echocardiography assessment of left ventricular ejection fraction pre- and post-training.
Pre-training and immediately post 4-week altitude training
Myocardial Thickness
Time Frame: Pre-training and immediately post 4-week altitude training
Measurement of interventricular septum and left ventricular posterior wall thickness by echocardiography.
Pre-training and immediately post 4-week altitude training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Mass
Time Frame: Pre-training and immediately post 4-week altitude training
Skeletal muscle mass measured pre- and post-training.
Pre-training and immediately post 4-week altitude training
Red Blood Cell Count
Time Frame: Pre-training and immediately post 4-week altitude training
RBC count measured from venous blood samples pre- and post-intervention.
Pre-training and immediately post 4-week altitude training
Hemoglobin
Time Frame: Pre-training and immediately post 4-week altitude training
Hemoglobin concentration measured from venous blood samples.
Pre-training and immediately post 4-week altitude training
Hematocrit
Time Frame: Pre-training and immediately post 4-week altitude training
Hematocrit levels measured pre- and post-training.
Pre-training and immediately post 4-week altitude training
Erythropoietin
Time Frame: Pre-training and immediately post 4-week altitude training
Plasma EPO concentration measured from venous blood samples.
Pre-training and immediately post 4-week altitude training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 25, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

May 21, 2026

First Submitted That Met QC Criteria

May 28, 2026

First Posted (Actual)

May 29, 2026

Study Record Updates

Last Update Posted (Actual)

May 29, 2026

Last Update Submitted That Met QC Criteria

May 28, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FCSD/DPPESS-2026/003

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on 4-Week Altitude Training

Subscribe